J
Jennifer Sharpe Potter
Researcher at Harvard University
Publications - 112
Citations - 4313
Jennifer Sharpe Potter is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Buprenorphine. The author has an hindex of 31, co-authored 105 publications receiving 3502 citations. Previous affiliations of Jennifer Sharpe Potter include Boston University & Fenway Health.
Papers
More filters
Journal ArticleDOI
Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories
Petra Jacobs,Alfonso Ang,Maureen Hillhouse,Andrew J. Saxon,Suzanne Nielsen,Paul Wakim,Barbara E. Mai,Larissa J. Mooney,Jennifer Sharpe Potter,Jack Blaine +9 more
TL;DR: This study supports the use of an objective measure of opioid withdrawal (COWS) during BUP induction to improve retention early in treatment and suggests that participants with higher baseline COWS whose BUP doses were raised more quickly were less likely to drop out in the first 7 days.
Journal ArticleDOI
eQuality: a Process Model to Develop an Integrated, Comprehensive Medical Education Curriculum for LGBT, Gender Nonconforming, and DSD Health
Amy Holthouser,Susan Sawning,Katie F. Leslie,V. Faye Jones,Stacie Steinbock,Emily J Noonan,Leslee J. Martin,Laura A Weingartner,Jennifer Sharpe Potter,John A. Davis,Kristen L. Eckstrand,M. Ann Shaw +11 more
TL;DR: In this paper, the authors developed an integrated educational model, eQuality, that sought to drive educational and system innovation by teaching and assessing the acquisition of attitudes, knowledge, and skills needed to provide competent care for LGBT/GNC/DSD individuals.
Journal ArticleDOI
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.
Dennis C. Turk,Alec B. O'Connor,Robert H. Dworkin,Amina Chaudhry,Nathaniel P. Katz,Edgar H. Adams,John S. Brownstein,Sandra D. Comer,Richard C. Dart,Nabarun Dasgupta,Richard A. Denisco,Michael Klein,Deborah B. Leiderman,Robert Lubran,Bob A. Rappaport,James P. Zacny,Harry Ahdieh,Laurie B. Burke,Penney Cowan,Petra Jacobs,Richard Malamut,John D. Markman,Edward Michna,Pamela Palmer,Sarah Peirce-Sandner,Jennifer Sharpe Potter,Srinivasa N. Raja,Christine Rauschkolb,Carl L. Roland,Lynn R. Webster,Roger D. Weiss,Kerry Wolf +31 more
TL;DR: A consensus meeting that was organized to propose recommendations for the types of clinical studies that can be used to assess the abuse deterrence of different opioid formulations recommended that the research conducted to evaluate abuse deterrence should include studies assessing abuse liability.
Journal ArticleDOI
Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults
Madina Agénor,Madina Agénor,Jaclyn M. White Hughto,Jaclyn M. White Hughto,Sarah M. Peitzmeier,Jennifer Sharpe Potter,Jennifer Sharpe Potter,Jennifer Sharpe Potter,Madeline B. Deutsch,Dana J. Pardee,Sari L. Reisner +10 more
TL;DR: Department of Social andBehavioral Sciences, Harvard T.H.Chan School of Public Health, Boston,MA, USA; The Fenway Institute, FenwayHealth,Boston, MA, USA.
BookDOI
Trauma, Resilience, and Health Promotion in LGBT Patients
TL;DR: The first € price and the £ and $ price are net prices, subject to local VAT as discussed by the authors, and they are subject to change without notice. All prices exclusive of carriage charges.